Capital Fund Management S.A. Ionis Pharmaceuticals Inc Call Options Transaction History

Capital Fund Management S.A.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2019 Feb 13, 2020	SELL	$53.85 - $65.27 $166,935 - $202,337	-3,100 Reduced 35.63%	5,600 $338,000
Q3 2019 Nov 13, 2019	SELL	$59.06 - $72.15 $590,600 - $721,500	-10,000 Reduced 53.48%	8,700 $521,000
Q2 2019 Aug 12, 2019	BUY	$62.09 - $86.14 $1.01 Million - $1.4 Million	16,200 Added 648.0%	18,700 $1.2 Million
Q1 2019 May 13, 2019	BUY	$52.92 - $81.17 $132,300 - $202,925	2,500 New	2,500 $203,000

404

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.1B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.